GetTopicDetailResponse(id=02cc4252e0f, topicName=復發(fā)性卒中, introduction=復發(fā)性卒中, content=null, image=null, comments=1, allHits=2075, url=https://h5.medsci.cn/topic?id=42527, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=29132, tagList=[TagDto(tagId=29132, tagName=復發(fā)性卒中)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2205621, encodeId=fa9e220562125, content=<a href='/topic/show?id=6cdd13883c9' target=_blank style='color:#2F92EE;'>#PCSK9抑制劑#</a> <a href='/topic/show?id=02cc4252e0f' target=_blank style='color:#2F92EE;'>#復發(fā)性卒中#</a>, objectTitle=JNNP：PSCK9 抑制劑可減少無癥狀顱內動脈粥樣硬化性狹窄患者的早期復發(fā)性中風, objectType=article, longId=826627, objectId=7d5f82662e50, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/type2diabetes-s18-plaque-in-artery.jpg, objectUrl=/article/show_article.do?id=7d5f82662e50, replyNumber=0, likeNumber=111, createdTime=2024-05-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7d5f82662e50, moduleTitle=JNNP：PSCK9 抑制劑可減少無癥狀顱內動脈粥樣硬化性狹窄患者的早期復發(fā)性中風, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7d5f82662e50)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2186916, encodeId=743b2186916e7, content=<a href='/topic/show?id=02cc4252e0f' target=_blank style='color:#2F92EE;'>#復發(fā)性卒中#</a> <a href='/topic/show?id=7cd689586dd' target=_blank style='color:#2F92EE;'>#血管反應性#</a>, objectTitle=Stroke：腦血管反應性受損的癥狀性大血管疾病患者復發(fā)中風的風險增加近10倍！, objectType=article, longId=813051, objectId=b46b81305123, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240210/1707572068494_2299762.png, objectUrl=/article/show_article.do?id=b46b81305123, replyNumber=0, likeNumber=114, createdTime=2024-02-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b46b81305123, moduleTitle=Stroke：腦血管反應性受損的癥狀性大血管疾病患者復發(fā)中風的風險增加近10倍！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b46b81305123)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=895279, encodeId=bb088952e9e6, content=未確定栓塞性<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>病史的患者中，<a href='/topic/show?id=23959394eda' target=_blank style='color:#2F92EE;'>#達比加群#</a>在預防<a href='/topic/show?id=02cc4252e0f' target=_blank style='color:#2F92EE;'>#復發(fā)性卒中#</a>方面不優(yōu)于<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>，阿司匹林的位置仍然不容易動搖, objectTitle=NEJM：達比加群在未確定栓塞性卒中病史的患者中的預防作用, objectType=article, longId=192671, objectId=4b3b1926e1a0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/138r.jpg, objectUrl=/article/show_article.do?id=4b3b1926e1a0, replyNumber=0, likeNumber=265, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b3b1926e1a0, moduleTitle=NEJM：達比加群在未確定栓塞性卒中病史的患者中的預防作用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4b3b1926e1a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
